[Current evidence about atomoxetine. A therapeutic alternative for the treatment of attention deficit hyperactivity disorder].

Velásquez-Tirado, J D; Peña, J A

[Current evidence about atomoxetine. A therapeutic alternative for the treatment of attention deficit hyperactivity disorder]. / Evidencia actual sobre la atomoxetina. Alternativa terapéutica para el trastorno por déficit de atención e hiperactividad.

Velásquez-Tirado, J D; Peña, J A.

Affiliation

Velásquez-Tirado JD; Psiquiatría de Enlace, Universidad El Bosque-Clínica Reina Sofía, Bogotá, Colombia.

Rev Neurol ; 41(8): 493-500, 2005.

Article in Es | MEDLINE | ID: mdl-16224736

Subject(s)

Attention Deficit Disorder with Hyperactivity/drug therapy; Propylamines; Atomoxetine Hydrochloride; Central Nervous System Stimulants/therapeutic use; Clinical Trials as Topic; Dopamine/metabolism; Humans; Methylphenidate/therapeutic use; Norepinephrine/metabolism; Norepinephrine Plasma Membrane Transport Proteins/metabolism; Propylamines/adverse effects; Propylamines/pharmacokinetics; Propylamines/therapeutic use

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Propylamines / Attention Deficit Disorder with Hyperactivity Limits: Humans Language: Es Journal: Rev Neurol Year: 2005 Document type: Article Affiliation country: Colombia Country of publication: Spain

Search on Google

Add to My VHL

XML

PubMed Links